Abstract: According to one aspect of the present disclosure, a device comprises one or more processors, wherein the one or more processors are configured to: obtain first data about a component disposed on a board, determine whether or not a model for a first class corresponding to the first data is stored in one or more memories, upon a determination that the model for the first class is stored in the one or more memories, determine whether or not the first data corresponds to the first class using the model, upon a determination that the model for the first class is not stored in the one or more memories, determine whether or not the first data corresponds to the first class using second data corresponding to the first class, and transmit information indicating whether or not the first data corresponds to the first class to an external device.

Abstract: Provided herein is a method for treating a monocarboxylate transporter MCT4-mediated disorder in a subject in need thereof. The method comprises the step of administering to the subject a compound of structural Formula I and/or a salt thereof. The treatment of the monocarboxylate transporter MCT4-mediated disorder may inhibit activity of MCT4, or a mutant thereof, sometimes with at least a 100-fold selectivity for MCT4 over MCT1.

Abstract: An extendable augmented reality (AR) system for recognizing user-selected objects in different contexts. A user may select certain entities (text, objects, etc.) that are viewed on an electronic device and create notes or additional content associated with the selected entities. The AR system may remember those entities and indicate to the user when those entities are encountered by the user in a different context, such as in a different application, on a different device, etc. The AR system offers the user the ability to access the user created note or content when the entities are encountered in the new context.

Abstract: A method for processing one or more histological images captured by a medical imaging device is disclosed. In this method, the histological image is received, and target regions each of which corresponds to a candidate type of tissue are identified based on a predictive model associating one more sample histological images with one or more sample target histological images. One or more display characteristics associated with the identified at least one target histological image is applied to the histological image.

Abstract: Provided herein is a method for treating a monocarboxylate transporter MCT4-mediated disorder in a subject in need thereof. The method comprises the step of administering to the subject a compound of structural Formula I and/or a salt thereof. The treatment of the monocarboxylate transporter MCT4-mediated disorder may inhibit activity of MCT4, or a mutant thereof, sometimes with at least a 100-fold selevtivity for MCT4 over MCT1.

Abstract: A method, performed by a computer, for volumetrically determining a mid-sagittal plane (MSP) from a plurality of magnetic resonance (MR) images of a brain is disclosed. The plurality of MR images is received and converted into a 3D volume image defined in a 3D coordinate space. Semantic segmentation of an anterior commissure (AC) region, a posterior commissure (PC) region, and a third ventricle region in the 3D volume image is performed based on a pre-trained segmentation model to generate a 3D mask image labeled with the AC region, the PC region, and the third ventricle region. Based on the labeled 3D mask image, a 3D volumetric image of the segmented third ventricle region is constructed. The MSP is determined based on the 3D volumetric image of the third ventricle region.

Abstract: A robotic system for manipulating an electrical component between a first location and a second location, the system comprising: a movement element for moving a manipulation tool between the first location and the second location; the manipulation tool having one or more gripping elements for engaging the electrical component by grabbing the electrical component at the first location when the manipulation tool is positioned adjacent to the electrical component; and a testing system for implementing an electronic test of the electrical component while the electrical component is engaged by the manipulation tool, the testing system implementing the electronic test before the manipulation tool releases the electrical component; wherein upon reaching the second location the manipulation tool disengages with the electrical component, thereby reversing said engaging.

Abstract: A method, performed by a computer, for volumetrically determining a mid-sagittal plane (MSP) from a plurality of magnetic resonance (MR) images of a brain is disclosed. The plurality of MR images is received and converted into a 3D volume image defined in a 3D coordinate space. Semantic segmentation of an anterior commissure (AC) region, a posterior commissure (PC) region, and a third ventricle region in the 3D volume image is performed based on a pre-trained segmentation model to generate a 3D mask image labeled with the AC region, the PC region, and the third ventricle region. Based on the labeled 3D mask image, a 3D volumetric image of the segmented third ventricle region is constructed. The MSP is determined based on the 3D volumetric image of the third ventricle region.

Abstract: Provided herein is a method for treating a monocarboxylate transporter MCT4-mediated disorder in a subject in need thereof. The method comprises the step of administering to the subject a compound of structural Formula I and/or a salt thereof. The treatment of the monocarboxylate transporter MCT4-mediated disorder may inhibit activity of MCT4, or a mutant thereof, sometimes with at least a 100-fold selectivity for MCT4 over MCT1.

Abstract: There is provided a photocatalytic reactor including reaction chamber arranged to receive an airflow including one or more airborne contaminants. The reaction chamber includes a first inner surface, a second inner surface, a photo-catalyst for photocatalytic degradation of one or more of the contaminants disposed upon both the first inner surface and the second inner surface, and a light source arranged to illuminate at least a portion of the photo-catalyst disposed on the first inner surface and the second inner surface. The first inner surface and the second inner surface have distinct parabolic arc-shaped profiles and the profile of the first inner surface is a mirror image of the profile of the second inner surface. The first inner surface and the second inner surface may be consecutive.

Abstract: There is provided a photocatalytic reactor including a reaction chamber. The reaction chamber includes a first set of fins, a second set of fins, a photo-catalyst disposed upon at least one face of each fin, and a light source arranged to illuminate at least a portion of the photo-catalyst disposed on each fin. Each of the first set of fins is arranged such that a line extending from a base of the fin through a tip of the fin is directed to a first convergence point, and each of the second set of fins is arranged such that a line extending from a base of the fin through a tip of the fin is directed to a second convergence point. The first convergence point is different to the second convergence point, and both the first convergence point and the second convergence point are offset relative to a position of the light source.

Abstract: A system for checking modifications made to re-configurable hardware and software is described.

Abstract: Disclosed herein are compounds and compositions useful in the treatment of MCT4 mediated diseases, such as proliferative and inflammatory diseases, having the structure of Formula I: Methods of inhibition MCT4 activity in a human or animal subject are also provided.

Abstract: Provided herein is a method for treating a monocarboxylate transporter MCT4-mediated disorder in a subject in need thereof. The method comprises the step of administering to the subject a compound of structural Formula I and/or a salt thereof. The treatment of the monocarboxylate transporter MCT4-mediated disorder may inhibit activity of MCT4, or a mutant thereof, sometimes with at least a 100-fold selectivity for MCT4 over MCT1.

Abstract: Methods, devices, and systems for performing intermittent detection during analytical reactions are provided. Such methods facilitate collection of reaction data from disparate reaction times. Further, such methods are useful for reducing photo-induced damage of one or more reactants in an illuminated analytical reaction at a given reaction time. In preferred embodiments, the reaction mixture is subjected to at least one illuminated and non-illuminated period and allowed to proceed such that the time in which the reaction mixture is illuminated is less than a photo-induced damage threshold period.

Abstract: Disclosed herein are compounds and compositions useful in the treatment of MCT4 mediated diseases, such as proliferative and inflammatory diseases, having the structure of Formula I: Methods of inhibition MCT4 activity in a human or animal subject are also provided.

Abstract: Methods, devices, and systems for performing intermittent detection during analytical reactions are provided. Such methods facilitate collection of reaction data from disparate reaction times. Further, such methods are useful for reducing photo-induced damage of one or more reactants in an illuminated analytical reaction at a given reaction time. In preferred embodiments, the reaction mixture is subjected to at least one illuminated and non-illuminated period and allowed to proceed such that the time in which the reaction mixture is illuminated is less than a photo-induced damage threshold period.

Abstract: Systems and methods are described which determine, in real time, and without impeding the natural flow of vehicles, which vehicles entering a predetermined area is there for commercial purposes, and designate a charge for the commercial purpose.

Abstract: Provided herein is a method for treating a monocarboxylate transporter MCT4-mediated disorder in a subject in need thereof. The method comprises the step of administering to the subject a compound of structural Formula I and/or a salt thereof. The treatment of the monocarboxylate transporter MCT4-mediated disorder may inhibit activity of MCT4, or a mutant thereof, sometimes with at least a 100-fold selectivity for MCT4 over MCT1.